EP3661929
ISOCHROMAN COMPOUNDS AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.8.2018EP published:
14.7.2021EP application number:
18756100.6
EPO information:
European Patent Register
Max expiry date:
31.7.2038
Title:
ISOCHROMAN COMPOUNDS AND USES THEREOF
Timeline
Today
1.8.2018EP application
14.7.2021EP Publication
Owner
Name:
Sunovion Pharmaceuticals Inc.Address:
84 Waterford Drive, Marlborough, MA 01752, US
Name:
PGI Drug Discovery LLCAddress:
215 College Road, Paramus, NJ 07652, US
Inventor
Name:
BOWEN, Carrie, A.Address:
Marlborough, MA 01752, US
Name:
BURDI, Douglas, F.Address:
Marlborough, MA 01752, US
Name:
HEFFERNAN, Michele, L., R.Address:
Marlborough, MA 01752, US
Name:
HERMAN, Lee, W.Address:
Marlborough, MA 01752, US
Name:
XIE, LinghongAddress:
Marlborough, MA 01752, US
Priority
Number:
201762540249 PDate:
2.8.2017Country:
US
Classification
Categories:
C07D 405/04, C07D 413/04, C07D 417/04, A61P 25/08, A61K 31/55